Clinical parameters outweigh diffusion- and perfusion-derived MRI parameters in predicting survival in newly diagnosed glioblastoma
- PMID: 27298312
- PMCID: PMC5744248
- DOI: 10.1093/neuonc/now122
Clinical parameters outweigh diffusion- and perfusion-derived MRI parameters in predicting survival in newly diagnosed glioblastoma
Abstract
Background: The purpose of this study was to determine the relevance of clinical data, apparent diffusion coefficient (ADC), and relative cerebral blood volume (rCBV) from dynamic susceptibility contrast (DSC) perfusion and the volume transfer constant (ktrans) from dynamic contrast-enhanced (DCE) perfusion for predicting overall survival (OS) and progression-free survival (PFS) in newly diagnosed treatment-naïve glioblastoma patients.
Methods: Preoperative MR scans including standardized contrast-enhanced T1 (cT1), T2 - fluid-attenuated inversion recovery (FLAIR), ADC, DSC, and DCE of 125 patients with subsequent histopathologically confirmed glioblastoma were performed on a 3 Tesla MRI scanner. ADC, DSC, and DCE parameters were analyzed in semiautomatically segmented tumor volumes on contrast-enhanced (CE) cT1 and hyperintense signal changes on T2 FLAIR (ED). Univariate and multivariable Cox regression analyses including age, sex, extent of resection (EOR), and KPS were performed to assess the influence of each parameter on OS and PFS.
Results: Univariate Cox regression analysis demonstrated a significant association of age, KPS, and EOR with PFS and age, KPS, EOR, lower ADC, and higher rCBV with OS. Multivariable analysis showed independent significance of male sex, KPS, EOR, and increased rCBVCE for PFS, and age, sex, KPS, and EOR for OS.
Conclusions: MRI parameters help to predict OS in a univariate Cox regression analysis, and increased rCBVCE is associated with shorter PFS in the multivariable model. In summary, however, our findings suggest that the relevance of MRI parameters is outperformed by clinical parameters in a multivariable analysis, which limits their prognostic value for survival prediction at the time of initial diagnosis.
Keywords: MRI; diffusion; glioblastoma; perfusion; survival.
© The Author(s) 2016. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Figures

Similar articles
-
Association of overall survival in patients with newly diagnosed glioblastoma with contrast-enhanced perfusion MRI: Comparison of intraindividually matched T1 - and T2 (*) -based bolus techniques.J Magn Reson Imaging. 2015 Jul;42(1):87-96. doi: 10.1002/jmri.24756. Epub 2014 Sep 22. J Magn Reson Imaging. 2015. PMID: 25244574
-
Apparent diffusion coefficient and tumor volume measurements help stratify progression-free survival of bevacizumab-treated patients with recurrent glioblastoma multiforme.Neuroradiol J. 2019 Aug;32(4):241-249. doi: 10.1177/1971400919847184. Epub 2019 May 8. Neuroradiol J. 2019. PMID: 31066622 Free PMC article.
-
Relative cerebral blood volume is a potential predictive imaging biomarker of bevacizumab efficacy in recurrent glioblastoma.Neuro Oncol. 2015 Aug;17(8):1139-47. doi: 10.1093/neuonc/nov028. Epub 2015 Mar 9. Neuro Oncol. 2015. PMID: 25754089 Free PMC article.
-
Imaging biomarkers guided anti-angiogenic therapy for malignant gliomas.Neuroimage Clin. 2018 Jul 5;20:51-60. doi: 10.1016/j.nicl.2018.07.001. eCollection 2018. Neuroimage Clin. 2018. PMID: 30069427 Free PMC article. Review.
-
Advanced magnetic resonance imaging in glioblastoma: a review.Chin Clin Oncol. 2017 Aug;6(4):40. doi: 10.21037/cco.2017.06.28. Chin Clin Oncol. 2017. PMID: 28841802 Review.
Cited by
-
Hemodynamic Imaging in Cerebral Diffuse Glioma-Part B: Molecular Correlates, Treatment Effect Monitoring, Prognosis, and Future Directions.Cancers (Basel). 2022 Mar 5;14(5):1342. doi: 10.3390/cancers14051342. Cancers (Basel). 2022. PMID: 35267650 Free PMC article. Review.
-
Relaxation-compensated amide proton transfer (APT) MRI signal intensity is associated with survival and progression in high-grade glioma patients.Eur Radiol. 2019 Sep;29(9):4957-4967. doi: 10.1007/s00330-019-06066-2. Epub 2019 Feb 26. Eur Radiol. 2019. PMID: 30809720
-
Magnetic Resonance Imaging of Primary Adult Brain Tumors: State of the Art and Future Perspectives.Biomedicines. 2023 Jan 26;11(2):364. doi: 10.3390/biomedicines11020364. Biomedicines. 2023. PMID: 36830900 Free PMC article. Review.
-
Multi-parametric and multi-regional histogram analysis of MRI: modality integration reveals imaging phenotypes of glioblastoma.Eur Radiol. 2019 Sep;29(9):4718-4729. doi: 10.1007/s00330-018-5984-z. Epub 2019 Feb 1. Eur Radiol. 2019. PMID: 30707277 Free PMC article.
-
Prognostic value of preoperative dynamic contrast-enhanced MRI perfusion parameters for high-grade glioma patients.Neuroradiology. 2016 Dec;58(12):1197-1208. doi: 10.1007/s00234-016-1741-7. Epub 2016 Oct 29. Neuroradiology. 2016. PMID: 27796446 Free PMC article.
References
-
- Mazurowski MA, Zhang J, Peters KB, Hobbs H. Computer-extracted MR imaging features are associated with survival in glioblastoma patients. J Neurooncol. 2014;120(3):483–488. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical